| Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer DQ Huang, AG Singal, Y Kono, DJH Tan, HB El-Serag, R Loomba Cell metabolism 34 (7), 969-977. e2, 2022 | 219 | 2022 |
| Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis J Quek, KE Chan, ZY Wong, C Tan, B Tan, WH Lim, DJH Tan, ASP Tang, ... The lancet Gastroenterology & hepatology 8 (1), 20-30, 2023 | 178 | 2023 |
| The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell Metabolism 35 (3), 414-428. e3, 2023 | 173 | 2023 |
| Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta … DJH Tan, CH Ng, SY Lin, XH Pan, P Tay, WH Lim, M Teng, N Syn, G Lim, ... The Lancet Oncology 23 (4), 521-530, 2022 | 160 | 2022 |
| An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023 | 143 | 2023 |
| Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals KE Chan, TJL Koh, ASP Tang, J Quek, JN Yong, P Tay, DJH Tan, WH Lim, ... The Journal of Clinical Endocrinology & Metabolism 107 (9), 2691-2700, 2022 | 124 | 2022 |
| Global incidence and prevalence of nonalcoholic fatty liver disease MLP Teng, CH Ng, DQ Huang, KE Chan, DJH Tan, WH Lim, JD Yang, ... Clinical and Molecular Hepatology 29 (Suppl), S32, 2023 | 121 | 2023 |
| Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019 B Chong, J Jayabaskaran, G Kong, YH Chan, YH Chin, R Goh, S Kannan, ... EClinicalMedicine 57, 2023 | 75 | 2023 |
| Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis CH Ng, WH Lim, GEH Lim, DJH Tan, N Syn, MD Muthiah, DQ Huang, ... Clinical Gastroenterology and Hepatology 21 (4), 931-939. e5, 2023 | 67 | 2023 |
| Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH DJH Tan, VW Setiawan, CH Ng, WH Lim, MD Muthiah, EX Tan, YY Dan, ... Hepatology 77 (4), 1150-1163, 2023 | 63 | 2023 |
| Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals ASP Tang, KE Chan, J Quek, J Xiao, P Tay, M Teng, KS Lee, SY Lin, ... Clinical and Molecular Hepatology 28 (3), 483, 2022 | 58 | 2022 |
| Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD-a systematic review and meta-analysis A Tang, CH Ng, PH Phang, KE Chan, YH Chin, CE Fu, RW Zeng, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (7), 1750-1760. e12, 2023 | 57 | 2023 |
| Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease J Xiao, LKE Lim, CH Ng, DJH Tan, WH Lim, CSH Ho, EXX Tan, AJ Sanyal, ... Frontiers in medicine 8, 691696, 2021 | 57 | 2021 |
| The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019 B Chong, G Kong, K Shankar, HSJ Chew, C Lin, R Goh, YH Chin, ... Metabolism 141, 155402, 2023 | 51 | 2023 |
| The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease CH Ng, KE Chan, YH Chin, RW Zeng, PC Tsai, WH Lim, DJH Tan, ... Clinical and Molecular Hepatology 28 (3), 565, 2022 | 50 | 2022 |
| Impact of the COVID-19 pandemic on the epidemiology of out-of-hospital cardiac arrest: a systematic review and meta-analysis SE Teoh, Y Masuda, DJH Tan, N Liu, LJ Morrison, MEH Ong, AL Blewer, ... Annals of intensive care 11, 1-14, 2021 | 49 | 2021 |
| The influence of diabetes on postoperative complications following colorectal surgery DJH Tan, CYL Yaow, HT Mok, CH Ng, CH Tai, HY Tham, FJ Foo, ... Techniques in coloproctology 25, 267-278, 2021 | 47 | 2021 |
| Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12 620 736 individuals J Quek, CH Ng, ASP Tang, N Chew, M Chan, CM Khoo, CP Wei, YH Chin, ... Endocrine Practice 28 (7), 667-672, 2022 | 46 | 2022 |
| Placebo effect on progression and regression in NASH: evidence from a meta‐analysis CH Ng, J Xiao, WH Lim, YH Chin, JN Yong, DJH Tan, P Tay, N Syn, R Foo, ... Hepatology 75 (6), 1647-1661, 2022 | 43 | 2022 |
| Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng, DJH Tan, WH Lim, ... Gut 72 (11), 2138-2148, 2023 | 37 | 2023 |
